The efficacy of induction chemotherapy or adjuvant chemotherapy added to concurrent chemoradiotherapy in T3-4N0-1M0 nasopharyngeal carcinoma: a propensity score-matched analysis-Reference-Cited by-同舟云学术

The efficacy of induction chemotherapy or adjuvant chemotherapy added to concurrent chemoradiotherapy in T3-4N0-1M0 nasopharyngeal carcinoma: a propensity score-matched analysis

Published:2023-11-15 Issue:1 Volume:24 Page:
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Zhong Qiulu¹²,Luo Danjing¹²^ORCID,Li Xiangde²,Du Qinghua²,Liang Qianfu²,Liu Wenqi²^ORCID,Li Jian²,Zhu Xiaodong¹³^ORCID

Affiliation:

1. Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, China

2. Department of Radiation Oncology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China

3. Department of Radiation Oncology, Wuming Hospital of Guangxi Medical University, Nanning, China

Funder

Middle-aged and Young Teachers’ Basic Ability Promotion Project of Guangxi

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384047.2023.2274121

Reference30 articles.

1. The prevalence and prevention of nasopharyngeal carcinoma in China

2. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

3. Nasopharyngeal carcinoma

4. Clinical treatment considerations in the intensity-modulated radiotherapy era for patients with N0-category nasopharyngeal carcinoma and enlarged neck lymph nodes

5. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial